Introduction
A small protein modifier, ubiquitin, is the building block of a repertoire of molecular signals spanning from single ubiquitin to ubiquitin chains of different linkage used for posttranslational modification of dozens of cellular proteins (Hershko and Ciechanover, 1998) . The seven lysines (K) of ubiquitin (K6, K11, K27, K29, K33, K48, and K63) and the amino-terminal methionine (M1) are connected to the C-terminal glycine for chain assembly, generating polymers (Ikeda and Dikic, 2008; Iwai and Tokunaga, 2009) . Ubiquitin signals are recognized and processed by specialized ubiquitin-binding domains (UBDs) that form transient, noncovalent interactions either with ubiquitin moieties or with the linkage region in their chains. So far, roughly 200 intracellular proteins have been recognized to contain one or more UBDs ). Ubiquitin-UBD interactions regulate almost every aspect of cellular physiology, including protein degradation, receptor trafficking, DNA repair, cell-cycle progression, gene transcription, autophagy, and apoptosis (recently reviewed in Deshaies and Joazeiro, 2009; Kirkin et al., 2009; Raiborg and Stenmark, 2009; Ulrich and Walden, 2010; Wickliffe et al., 2009; Winget and Mayor, 2010 ).
Yet, very little is known about the nature of ubiquitin signals and the dynamics of their interpretation by UBDs in the highly crowded molecular environment of the cell. In particular, it remains unclear how a relatively limited pool of signals (ubiquitin chains and UBDs) with partially overlapping biochemical properties can orchestrate the localization and function of thousands of proteins involved in very different cellular processes. Here we summarize the most recent advances in understanding specificity determinants in ubiquitin signaling and discuss future challenges in the development of sensitive and reliable methods for monitoring spatial and temporal patterns of ubiquitination in vivo.
Diversity of Ubiquitin Signals
Despite its relatively rigid globular structure, ubiquitin is one of the most versatile signaling molecules in the cell. Although the surface of ubiquitin is mostly composed of polar residues, it is through its few hydrophobic patches that it interacts with most UBDs Winget and Mayor, 2010) . Moreover, the presence of seven lysine residues and the N-terminal methionine within ubiquitin that can be fused to the C-terminal diglycine motif of another ubiquitin allows the formation of polymeric chains endowed with flexibility, as in the case of K63-linked or M1-linked chains (often referred to as linear) (Ikeda and Dikic, 2008; Iwai and Tokunaga, 2009 ). K48-linked and K11-linked chains adopt a more rigid conformation, in which ubiquitin monomers are tightly packed against each other. This creates unique modules composed of aligned ubiquitin moieties in which the hydrophobic patch containing isoleucine 44 is either embedded or facing out toward the surface (Pickart and Fushman, 2004; Bremm et al., 2010; Matsumoto et al., 2010) . Conversely, K6-linked chains form an asymmetric compact conformation distinct from any other known type of ubiquitin chain (Virdee et al., 2010) . The possibility of heterotypic ubiquitin chains (that is, with mixed linkages) has been shown in vitro, but their presence and biological functions in vivo remain to be confirmed. Altogether, monoubiquitin and homotypic polyubiquitin chains comprise no more than ten signal types. However, the ability to synthesize homotypic chains of various lengths indicates that the repertoire of ubiquitin signals in the cell may be larger than expected.
Signals Decoders: Ubiquitin-Binding Domains Ubiquitin signals are read and processed by UBDs that bind noncovalently to mono-or polyubiquitin chains. To date, five structural folds are known with more than 20 UBDs identified overall . UBDs are commonly a-helical structures, zinc fingers, pleckstrin homology (PH) folds, or similar to the ubiquitin-conjugating (Ubc) domain present in E2 enzymes ). In the majority of cases, isolated UBDs preferentially bind to monoubiquitin via a conserved hydrophobic patch surrounding isoleucine 44. The measured affinity of isolated UBDs for monoubiquitin typically falls in the micromolar range Winget and Mayor, 2010) . In certain cases, monoubiquitin-UBD interactions have also been demonstrated in the context of endogenous fullsize proteins. For example, UBDs present in Y family polymerases performing DNA translesion synthesis bind the monoubiquitinated sliding clamp PCNA (Bienko et al., 2005) , and monoubiquitinated transmembrane receptors are recognized by endocytic sorting proteins containing diverse UBDs (Hicke and Dunn, 2003) . The affinity of UBD-containing proteins for their monoubiquitinated targets in the cellular environment, however, may be different from that inferred from in vitro studies. In fact, the way ubiquitin signals are decoded in cells may be influenced by multiple factors, including the presence of tandem copies of one UBD in the same protein, oligomerization, and protein compartmentalization (reviewed in Dikic et al., 2009; Winget and Mayor, 2010) .
In addition to monoubiquitin, many UBDs display either relative or absolute selectivity for certain types of chains (Ikeda and Dikic, 2008; Dikic et al., 2009; Winget and Mayor, 2010) . For instance, the Pru (Plextrin receptor for ubiquitin) domain in the proteasome receptor Rpn13 preferentially interacts with K48-linked diubiquitin (Husnjak et al., 2008) , and the NZF (Npl4 zinc finger) domain in TAK1-binding protein 2 (TAB2) binds specifically to K63-linked ubiquitin (Kulathu et al., 2009; Sato et al., 2009 ). In contrast, UBDs in NEMO and ABIN proteins (UBAN) bind linear diubiquitin chains with approximately 100-fold higher affinity than K63 or K48 chains, and binding to monoubiqutitin could not be detected (Rahighi et al., 2009; Lo et al., 2009 ). The selectivity of UBAN for linear chains has been explained by the observation that a NEMO dimer binds symmetrically to linear diubiquitin, involving direct interactions with residues exposed in the glycine-methionine linkages (Rahighi et al., 2009 ). In addition, the crystal structures of the NZF domain of TAB2 and TAB3 in complex with K63-linked diubiquitin have shown a two-sided ubiquitinbinding surface thanks to a flexible K-linkage positioned away from the interaction surface (Kulathu et al., 2009; Sato et al., 2009) . Linkage selectivity can also result from multivalent interaction between tandem UBD arrays in a given protein and ubiquitin monomers or linkages in a polyubiquitin chain. Tandem ubiquitin-interacting motifs (UIMs) in the DNA double-strand break response protein Rap80 are positioned to cross two K63-linked monomers, whereas Ataxin-3 UIMs display K48 avidity (Sims and Cohen, 2009 ). The proteasome receptor S5a has two UIMs separated by linker regions and shows a 10-fold higher affinity for diubiquitin over monoubiquitin (Zhang et al., 2009 ). These observations suggest that the function of tandem UBD arrays is to increase the affinity for a given ubiquitinated substrate rather than simultaneously binding multiple substrates.
Specificity and Plasticity of Ubiquitin Signaling
Historically, distinct ubiquitin signals have been linked to specific cellular functions. For example, K48-linked chains, also known as ''classical'' ubiquitin chains, were originally described as the signal that targets substrates for proteasomal degradation (Hershko and Ciechanover, 1998) . Nonclassical linkage types, such as K63-, K11-, or M1-linked chains are instead associated with DNA repair regulation, cell-cycle progression, innate immunity, and inflammation (Ikeda and Dikic, 2008; Iwai and Tokunaga, 2009; Matsumoto et al., 2010; Wickliffe et al., 2009) . Recent reports, however, have challenged the notion that distinct chain types exclusively regulate specific processes in the cell. For instance, nonclassical ubiquitin signals, such as K11 chains generated by the anaphasepromoting complex (APC/C), can also target selected substrates for proteasomal degradation (Jin et al., 2008) . In yeast, cyclin B1 is modified by a mix of K48-, K63-, and K11-linked chains rather than by K48 chains alone . This heterogeneous pool is sufficient to bind to proteasomal ubiquitin receptors and drive cyclin B1 degradation . Furthermore, linear chains, initially discovered as activators of the NF-kB pathway , can also trigger proteasomal degradation when fused to artificial substrates (Zhao and Ulrich, 2010) .
So, how is functional specificity of ubiquitin signaling achieved in vivo? Even though evidence indicates that specific chain types control distinct molecular processes, as clearly exemplified by NF-kB signaling, we speculate that additional signals (monoubiquitin and chains with different linkage and length) can control the same molecular process with different kinetics and spatial constraints. It has also been speculated that unanchored ubiquitin chains can regulate NF-kB activation (Xia et al., 2009 ).
However, the importance of this regulatory mechanism in vivo remains to be further investigated. Therefore, the decoding of ubiquitin signals might be performed in vivo by different UBDs (not necessarily endowed with absolute selectivity toward monoubiquitin or a particular chain type) embedded in key proteins controlling a particular process. Although this scenario could allow a certain degree of plasticity in ubiquitin signaling, specificity might be determined by the localization and assembly of UBD-containing proteins and enzymes catalyzing ubiquitination reactions.
Catching Ubiquitin Signaling in the Act
The huge discrepancy between our current understanding of the ubiquitin system from in vitro studies compared to in vivo models stems from the fact that ubiquitination and its recognition and cleavage occur in milliseconds (Pierce et al., 2009) , therefore making it challenging to analyze these events in living systems. The first attempts to study ubiquitin signaling in vivo have used antibodies against monoubiquitin, polyubiquitin chains, or, more recently, selective linkages, including K11, K48, K63, and linear chains (Matsumoto et al., 2010; Newton et al., 2008; Wang et al., 2008; Tokunaga et al., 2009) (Figure 1A ). Raising linkage-selective antibodies is not easy, despite being urgently needed to provide tools to discriminate between different chain types in the cell. These antibodies were produced either by synthesizing peptides resembling specific linkage bonds (Wang et al., 2008; Tokunaga et al., 2009) or by using the phage-display method (Matsumoto et al., 2010; Newton et al., 2008) . Although chain-selective antibodies have been used to demonstrate specific chain formation in several biological settings (such as the NF-kB pathway and cell-cycle progression), their ability to monitor substrates with low abundance and the dynamics of chain (de)conjugation as well as their distribution in vivo are still very limited.
Monoclonal antibodies recognizing diglycine-modified lysines have been used in combination with mass spectrometry in efforts to increase the sensitivity of immune-based techniques (Xu et al., 2010) (Figure 1B) . These antibodies enrich for the C-terminal di-glycine motif of ubiquitin attached to the acceptor lysine following proteolysis of ubiquitinated proteins by trypsin (Figure 1B) . This method revealed more than 200 ubiquitinated proteins from human embryonic kidney 293 cells, the majority of which were previously unknown targets (Xu et al., 2010) . This strategy can be coupled to stable isotope labeling with amino acids in cell culture (SILAC) to quantitatively explore protein ubiquitination in diverse biological settings. However, it needs to be noted that this approach can neither detect short-lived proteins nor distinguish lysine modification by NEDD8.
The AQUA (absolute quantification) method developed in the Gygi laboratory is another promising approach to measure the dynamics of ubiquitin signaling in cells (Kirkpatrick et al., 2005) . AQUA relies on the use of stable isotope-labeled internal standard peptides that mimic those produced during tryptic digestion of ubiquitinated proteins of interest. In case of mono-or polyubiquitinated proteins, tryptic digestion produces a series of unbranched and di-glycinebranched peptides. Initial analysis of such mixtures allows identification of ubiquitination sites in the substrate and the type of ubiquitin chain linkage (such as monoubiquitination or K63-or K48-ubiquitin chains). Based on this information, substrate-, site-, and linkage-specific reference peptides are synthesized and used as quantitative internal standards, allowing for precise quantification of monoubiquitin and polyubiquitin chains by targeted proteomics approaches such as selective reaction monitoring. With this methodology, the stoichiometry of ubiquitin moieties on a protein of interest can be determined (Figure 2A ). Its simplicity and sensitivity, coupled with the current widespread availability of tandem mass spectrometers, makes AQUA the tool of choice for quantitatively measuring ubiquitin modifications directly in cell lysates .
What Is Known about Ubiquitin
Chain Length In Vivo? The methods described above are predicted to provide quantitative information on the repertoire of ubiquitin signals and ubiquitinated proteins generated in different biological settings. However, these methods cannot monitor the length of ubiquitin chains in vivo. At present, all our knowledge on their length in vivo relies on nonquantitative analysis of immunoblots. Several procedures have been designed to cause ubiquitin chains and polyubiquitinated substrates to accumulate in the cell to facilitate their detection, including the use of inhibitors of the proteasome and of deubiquitinating enzymes (DUBs). This has often led to the conclusion that high-mobility ubiquitin-positive smears observed on immunoblots represent the natural modification of substrates by very long ubiquitin chains. This, however, can be misleading because the combination of different ubiquitin signals (monoubiquitin or ubiquitin chains) on the same type of substrate can also yield high-mobility smears (Haglund et al., 2003; Huang et al., 2006) , and inhibition of DUBs and the proteasome may cause an overrepresentation of long ubiquitin chains that might not naturally occur in the cell.
The question of chain length is important given that chains with different topology and length may regulate different cellular functions. For instance, the length of K48-linked tetraubiquitin chains is optimized for interaction with proteasomal receptors (Pickart and Fushman, 2004) , as a ternary complex can be formed between the ubiquitin chains and proteasomal receptors Rpn13 and S5a (Zhang et al., 2009) . Moreover, given that trimming of ubiquitinated substrates occurs from the distal end of the chains, it seems that the length of K48-linked chains dictates the duration of proteasomal degradation (Lee et al., 2010) . Monoubiquitination can also drive proteins to proteasomal degradation (Shabek et al., 2009 ). These observations collectively suggest that the ubiquitin chain length required for proteasomal degradation is determined by the substrate's affinity for the proteasome and must be just high enough to allow processivity of the proteolytic process. This kind of adjustment is most likely controlled by a proteasome-associated complex, which is equipped with both ubiquitin Figure 1 . Antibodies for Ubiquitin Signals (A) Linkage-specific antibodies, such as a-lysine 11(K11)-, a-K48-, a-K63-linked ubiquitin chains and a-linear ubiquitin chains, can be applied for the detection of endogenous ubiquitination of a specific linkage type. (B) After trypsin digestion of total cell extracts, immunoprecipitation of the samples by a specific antibody against glycine-glycine-lysine peptides (a-GGK Ab) can enrich fragments with ubiquitinated K residues from both substrates and ubiquitin chains. Analysis by mass spectrometry enables the identification of new target proteins as well as sites of ubiquitination.
ligase (HUL5) and deubiquitinating (UBP6) activities (Crosas et al., 2006) .
In the case of the NF-kB pathway, distinct activation steps involve K63, linear, and K48 chains (Bianchi and Meier, 2009) , which are further edited (in length and topology) by ligases and DUBs (Wertz et al., 2004; Newton et al., 2008 ). An initial mechanism proposed for NFkB activation implicated long K63-linked chains in the recruitment of TAK1 and IKK kinases via their respective adaptor proteins TAB2 and NEMO (reviewed in Bianchi and Meier, 2009) . This model has been challenged by the demonstration that cells expressing ubiquitin lacking K63 have intact NF-kB signaling via tumor necrosis factor-a receptors (Xu et al., 2009) . Interestingly, based on available structures it appears that chain-selective UBDs in TAB2 and NEMO interact with K63-linked or linear diubiquitin chains, respectively (Kulathu et al., 2009; Rahighi et al., 2009; Sato et al., 2009) . Given that no data are available on the precise length of ubiquitin chains in the NF-kB pathway, it is tempting to speculate that diubiquitin chains are the fundamental units recognized by selective UBDs. However, UBDs also show promiscuous binding with lower affinities to other types of chains. Examples include the NZF domain of TAB2, which also binds K48 chains in solution (Kulathu et al., 2009) , and the UBAN domain in NEMO, which interacts with K63-and K48-linked chains longer than diubiquitin (Rahighi et al., 2009) . We speculate that diubiquitin units in longer chains may amplify signals that can be recognized by nonselective
UBDs. In such a scenario, short ubiquitin chains added to substrates will be preferentially decoded by linkageselective UBDs, whereas long chains may be promiscuously read by different UBDs, possibly placing chain length next to chain linkage type in determining ubiquitin-UBD selectivity.
Development of Sensors Using Selective UBDs
In order to measure the dynamics of ubiquitin chain formation/disassembly and their length in vivo, functional ubiquitin sensors are needed ( Figure 2B ). A recently engineered sensor (TUBE, tandem repeated ubiquitin entities) possesses four tandem UBA domains of either HR23 or ubiquitin 1 (Hjerpe et al., 2009) . The ubiquitin-binding capacity of TUBE is markedly higher for ubiquitin tetramers in comparison to monoubiquitin. In addition, the affinity of the interaction of TUBE with either K63-or K48-tetraubiquitin chains is much greater than that of a single UBA domain (Hjerpe et al., 2009 ). An intriguing feature of TUBE is its ability to protect ubiquitin chains from cleavage by blocking accessibility to DUBs.
The design principle of TUBE could be easily adapted to other UBDs: for example, a K63 chain-specific sensor could be created by fusing multiple NZF domains of TAB2 in tandem, a K48-specific sensor by merging multiple Pru domains of Rpn13, and a linear-specific sensor by arraying several copies of the UBAN domain of NEMO or ABINs. These UBD-derived ubiquitin sensors could be used to protect and purify substrates decorated with endogenous ubiquitin chains. They could also A) The workflow for the AQUA (absolute quantification) method of quantitative mass spectrometry is depicted. First, a representative tryptic peptide is selected based on initial proteomic sequencing experiments and then synthesized with a stable isotope at one residue for identification. The tryptic peptide sequence for lysine 48 (K48)-linked ubiquitin chains is indicated (upper panel). AQUA peptide standards are added to the sample (cell lysates or immunocomplexes) prior to trypsin digestion and targeted proteomic analysis is performed using selective reaction monitoring. The amount of total protein and the extent of ubiquitination at that particular site can be determined by comparing the precise amounts of the unmodified and ubiquitinated versions of the peptide (lower panel). (B) Schematic models of ubiquitin sensors are shown. By using different ubiquitin-binding domains (UBDs), the sensor can be applied for specific linkage type of ubiquitin chains (left), such as K48, K63, and linear chains. Tandem UBDs may be used to determine the chain length (right). One UBD recognizes 1 unit of diubiquitin. The tag chosen depends on the experimental purposes. be used to determine the predominant linkage type within these chains by competition experiments and for measuring the length of ubiquitin polymers in their natural environment.
A further critical challenge will be to evaluate chain-specific ubiquitin sensors using advanced (high-throughput) singlecell or -molecule microscopy. This might permit the qualitative and quantitative assessment of ubiquitin chain formation and the interplay between different chain types in vivo. Analyzing additional properties, such as the spatial and temporal regulation of conjugation and deconjugation of ubiquitin chains as well as their length in vivo, could enable a highresolution, systems-level analysis of the ''ubiquitinome.'' Perspective Even though we have attained a sophisticated mechanistic understanding of the ubiquitin system, it has been more difficult to analyze the orchestration of its functions in vivo. Within the cellular environment, ubiquitin signals must select the correct binding partner at the right place and time, ensuring accurate signaling. To understand the specificity and dynamics of the ubiquitin system in its biological context, it is critical that highly sensitive methods, such as mass spectrometry and advanced microscopy, are deployed to measure key parameters, such as the amount of different ubiquitin signals, the kinetics of UBD-ubiquitin recognition, and the type and length of ubiquitin chains attached onto substrates in vivo. By shedding light onto these properties, we will gain a deeper understanding of one of the most important and widely used regulatory systems of cell physiology. 
